Suchergebnisse - "Pytel, Dariusz"

PubPharm (7)

1

Evaluation of the LDN-0060609 PERK Inhibitor as a Selective Treatment for Primary Open-Angle Glaucoma : An In Vitro Study on Human Retinal Astrocytes

enthalten in: International journal of molecular sciences | 2024

von Rozpędek-Kamińska, W. | Galita, G. | Saramowicz, K. | +5

2

Small-molecule inhibitors of the PERK-mediated Unfolded Protein Response signaling pathway in targeted therapy for colorectal cancer

enthalten in: Polski przeglad chirurgiczny | 2022

von Rozpedek-Kaminska, W. | Piotrzkowska, D. | Galita, G. | +5

3

The Potential Role of Small-Molecule PERK Inhibitor LDN-0060609 in Primary Open-Angle Glaucoma Treatment

enthalten in: International journal of molecular sciences | 2021

von Rozpędek-Kamińska, W. | Galita, G. | Siwecka, N. | +5

4

The PERK-Dependent Molecular Mechanisms as a Novel Therapeutic Target for Neurodegenerative Diseases

enthalten in: International journal of molecular sciences | 2020

von Rozpędek-Kamińska, W. | Siwecka, N. | Wawrzynkiewicz, A. | +4

5

Use of Small-molecule Inhibitory Compound of PERK-dependent Signaling Pathway as a Promising Target-based Therapy for Colorectal Cancer

enthalten in: Current cancer drug targets | 2020

von Rozpędek, W. | Pytel, D. | Wawrzynkiewicz, A. | +5

6

Dual role of Endoplasmic Reticulum Stress-Mediated Unfolded Protein Response Signaling Pathway in Carcinogenesis

enthalten in: International journal of molecular sciences | 2019

von Siwecka, N. | Rozpędek, W. | Pytel, D. | +5

7

Small molecule inhibitors of PERK-dependent signaling pathway as a novel, therapeutic molecular strategy in Alzheimer's disease treatment

enthalten in: Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego | 2016

von Rozpędek, W. | Pytel, D. | Diehl, J. | +1

1
[1]